Skip to main content
Home
  • Home
  • About
    • Who We Are
    • History
    • Governance
      • Board of Members
      • Board of Directors
      • Executive Management
      • Senior Management
    • Principal Investigators
    • Our Capacity
    • Partners
    • Collaborators
    • Sponsors
    • Careers
    • Tenders
      • Policies
    • Research
      • Research Themes
      • Studies
        • Ongoing Studies
        • Completed Studies
      • Laboratory
      • Pharmacy
      • Clinical Research Sites
      • Data Management
      • Regulatory
      • Publications
    • Capacity Building
      • Training
      • Projects
    • Community Engagement
      • Community Engagement Activities
      • Community Advisory Boards
    • Media
      • News
      • Newsletters
      • Press Releases
      • Annual Reports
      • Videos
    • Donate
    Menu

    Studies

    Status:Ongoing

    Find Out More
    Karabo Study: Immune Correlates of Tuberculosis and non-Tuberculosis Infectious Morbidity in Southern African HIV- Exposed, Uninfected Infants

    Status:Ongoing

    Find Out More
    Linking HIV Prevention and Postpartum Care: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a High-Risk Breastfeeding Population in Botswana (Tshireletso Study)

    Status:Ongoing

    Find Out More
    Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition

    Status:Ongoing

    Find Out More
    Mitigating the impact of COVID-19 effects in adolescent reproductive health through self-testing: a mixed methods pilot study: “ICHEKE”

    Status:Ongoing

    Find Out More
    Mopati: A Pilot HIV Treatment Partner Intervention in Botswana

    Status:Ongoing

    Find Out More
    Motsepe Wastewater Project

    Status:Ongoing

    Find Out More
    Multi-Country Aetiology of Genital Ulcer Study (MAGUS)

    Status:Ongoing

    Find Out More
    Neurodevelopment In HEU Children Exposed In Utero To Dolutegravir or Efavirenz and HIV-Unexposed Children (Motheo Study)

    Status:Ongoing

    Find Out More
    Open-label access to dolutegravir for HIV-1 infected children and adolescents completing IMPAACT Studies P1093 and P2019: GSK205858

    Status:Ongoing

    Find Out More
    Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age

    Status:Ongoing

    Find Out More
    Point-of-Care HIV Testing and Early Dolutegravir Use for Infants

    Status:Ongoing

    Find Out More
    Point-of-Care HIV Testing and Early Dolutegravir Use for Infants (Moso Study)

    Status:Ongoing

    Find Out More
    Post abortion care in Botswana: Impact of HIV status on outcomes

    Status:Ongoing

    Find Out More
    Post-acute sequelae of SARS-CoV-2 infection (PASC) / ‘Long Covid’: observational cohort: “Motlhala” Study

    Status:Ongoing

    Find Out More
    Potlako+ : A multilevel intervention to improve timely cancer detection and treatment initiation in Botswana

    Status:Ongoing

    Find Out More
    Prevalence and outcomes of the usage of lumbar puncture in patients who presented with central nervous system symptoms at Princess Marina Hospital during the period 01/01/2014 to 31/03/2021

    Status:Ongoing

    Find Out More
    PRomoting Equity for Pregnant Adolescents in REsearch (PREPARE) in Botswana

    Status:Ongoing

    Find Out More
    Safety, Tolerability, and Impact of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants with Both Chronic Hepatitis B and HIV; v1.0 May 27, 2022; IND #158394; Site 12701/Gaborone

    Status:Ongoing

    Find Out More
    Single, High-dose AmBisome to Reduce Excess mortality from Cryptococcal Meningitis (SHARE-CM)

    Status:Ongoing

    Find Out More
    SOLIDARITY Trial: An international (multisite)randomized trial of additional treatments for COVID-19 in hospitalized patients who are all receiving the local standard of care

    Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page 1
    • Page 2
    • Current page 3
    • Page 4
    • Page 5
    • Page 6
    • Next page Next ›
    • Last page Last »

    Media

    BHP Meets Vice President Gaolathe
    April 10, 2025
    BHP Meets Vice President Gaolathe
    Dr Wonderful Choga
    March 27, 2025
    2024 – 2025 Harvard Global Health Institute Visiting Scholars
    BHP strategy team
    January 28, 2025
    BHP holds two-day Strategy Retreat to shape Strategic Plan
    Dr Makhema and Hon. Minister Modise
    January 27, 2025
    BHP meets the new Minister of Health
    View All

    footer.png

     

    Botswana Harvard Health Partnership
    Princess Marina Hospital
    Plot No. 1836, Northring Road, Gaborone, Botswana
    Email: info@bhp.org.bw
    Tel: +267 3902671

    • f
    • t
    • l
    • y
    • Contact Us
    • Laboratory
    • Research Papers
    • Ongoing Studies
    • Register for Study Participation

    All Rights Reserved. Botswana Harvard Health Partnership © 2022

    Website Design and Development - MindQ

    • Home
    • About
      • Who We Are
      • History
      • Governance
        • Board of Members
        • Board of Directors
        • Executive Management
        • Senior Management
      • Principal Investigators
      • Our Capacity
      • Partners
      • Collaborators
      • Sponsors
      • Careers
      • Tenders
      • Policies
    • Research
      • Research Themes
      • Studies
        • Ongoing Studies
        • Completed Studies
      • Laboratory
      • Pharmacy
      • Clinical Research Sites
      • Data Management
      • Regulatory
      • Publications
    • Capacity Building
      • Training
      • Projects
    • Community Engagement
      • Community Engagement Activities
      • Community Advisory Boards
    • Media
      • News
      • Newsletters
      • Press Releases
      • Annual Reports
      • Videos
    • Donate